nodes	percent_of_prediction	percent_of_DWPC	metapath
Zanamivir—NEU2—Sphingolipid metabolism—VAPB—amyotrophic lateral sclerosis	0.0674	0.207	CbGpPWpGaD
Zanamivir—NEU2—Sphingolipid metabolism—VAPA—amyotrophic lateral sclerosis	0.0616	0.189	CbGpPWpGaD
Zanamivir—Lymphopenia—Riluzole—amyotrophic lateral sclerosis	0.0482	0.0714	CcSEcCtD
Zanamivir—Lung disorder—Riluzole—amyotrophic lateral sclerosis	0.0348	0.0517	CcSEcCtD
Zanamivir—Delusion—Riluzole—amyotrophic lateral sclerosis	0.0348	0.0517	CcSEcCtD
Zanamivir—Delirium—Riluzole—amyotrophic lateral sclerosis	0.0287	0.0425	CcSEcCtD
Zanamivir—NEU2—Post-translational protein modification—PIGW—amyotrophic lateral sclerosis	0.0232	0.0714	CbGpPWpGaD
Zanamivir—Ear pain—Riluzole—amyotrophic lateral sclerosis	0.021	0.0311	CcSEcCtD
Zanamivir—Increased appetite—Riluzole—amyotrophic lateral sclerosis	0.0191	0.0282	CcSEcCtD
Zanamivir—Anaphylactoid reaction—Riluzole—amyotrophic lateral sclerosis	0.0185	0.0274	CcSEcCtD
Zanamivir—Face oedema—Riluzole—amyotrophic lateral sclerosis	0.0173	0.0256	CcSEcCtD
Zanamivir—Dehydration—Riluzole—amyotrophic lateral sclerosis	0.0167	0.0247	CcSEcCtD
Zanamivir—Asthma—Riluzole—amyotrophic lateral sclerosis	0.0155	0.0229	CcSEcCtD
Zanamivir—Influenza—Riluzole—amyotrophic lateral sclerosis	0.0155	0.0229	CcSEcCtD
Zanamivir—Bronchitis—Riluzole—amyotrophic lateral sclerosis	0.0149	0.0221	CcSEcCtD
Zanamivir—NEU2—Metabolism of proteins—IGFALS—amyotrophic lateral sclerosis	0.0145	0.0447	CbGpPWpGaD
Zanamivir—Neutropenia—Riluzole—amyotrophic lateral sclerosis	0.0145	0.0214	CcSEcCtD
Zanamivir—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.0129	0.0192	CcSEcCtD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.0127	0.0392	CbGpPWpGaD
Zanamivir—Haemoglobin—Riluzole—amyotrophic lateral sclerosis	0.0124	0.0185	CcSEcCtD
Zanamivir—Haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.0124	0.0184	CcSEcCtD
Zanamivir—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.0123	0.0183	CcSEcCtD
Zanamivir—Erythema multiforme—Riluzole—amyotrophic lateral sclerosis	0.0117	0.0174	CcSEcCtD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.0117	0.0358	CbGpPWpGaD
Zanamivir—Chills—Riluzole—amyotrophic lateral sclerosis	0.0111	0.0165	CcSEcCtD
Zanamivir—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.0111	0.0164	CcSEcCtD
Zanamivir—NEU2—Metabolism of proteins—PIGW—amyotrophic lateral sclerosis	0.011	0.0339	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.0108	0.0333	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.0102	0.0313	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—XRN2—amyotrophic lateral sclerosis	0.0101	0.031	CbGpPWpGaD
Zanamivir—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.01	0.0148	CcSEcCtD
Zanamivir—Agitation—Riluzole—amyotrophic lateral sclerosis	0.00991	0.0147	CcSEcCtD
Zanamivir—Malaise—Riluzole—amyotrophic lateral sclerosis	0.00972	0.0144	CcSEcCtD
Zanamivir—Syncope—Riluzole—amyotrophic lateral sclerosis	0.00967	0.0143	CcSEcCtD
Zanamivir—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00948	0.014	CcSEcCtD
Zanamivir—Cough—Riluzole—amyotrophic lateral sclerosis	0.00941	0.0139	CcSEcCtD
Zanamivir—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.00934	0.0138	CcSEcCtD
Zanamivir—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00918	0.0136	CcSEcCtD
Zanamivir—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00918	0.0136	CcSEcCtD
Zanamivir—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.00915	0.0136	CcSEcCtD
Zanamivir—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.00912	0.0135	CcSEcCtD
Zanamivir—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.00907	0.0134	CcSEcCtD
Zanamivir—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00887	0.0132	CcSEcCtD
Zanamivir—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.0088	0.013	CcSEcCtD
Zanamivir—Infection—Riluzole—amyotrophic lateral sclerosis	0.00874	0.013	CcSEcCtD
Zanamivir—Shock—Riluzole—amyotrophic lateral sclerosis	0.00866	0.0128	CcSEcCtD
Zanamivir—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.00855	0.0127	CcSEcCtD
Zanamivir—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00839	0.0124	CcSEcCtD
Zanamivir—NEU2—Metabolism of proteins—YIF1A—amyotrophic lateral sclerosis	0.00835	0.0257	CbGpPWpGaD
Zanamivir—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00802	0.0119	CcSEcCtD
Zanamivir—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.00785	0.0116	CcSEcCtD
Zanamivir—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00765	0.0113	CcSEcCtD
Zanamivir—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00759	0.0112	CcSEcCtD
Zanamivir—Pain—Riluzole—amyotrophic lateral sclerosis	0.00753	0.0112	CcSEcCtD
Zanamivir—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00725	0.0107	CcSEcCtD
Zanamivir—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.0072	0.0107	CcSEcCtD
Zanamivir—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00699	0.0104	CcSEcCtD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.00699	0.0215	CbGpPWpGaD
Zanamivir—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00696	0.0103	CcSEcCtD
Zanamivir—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00696	0.0103	CcSEcCtD
Zanamivir—NEU2—Metabolism of proteins—EXOSC9—amyotrophic lateral sclerosis	0.00688	0.0211	CbGpPWpGaD
Zanamivir—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00648	0.00961	CcSEcCtD
Zanamivir—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00631	0.00936	CcSEcCtD
Zanamivir—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00602	0.00892	CcSEcCtD
Zanamivir—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00582	0.00863	CcSEcCtD
Zanamivir—NEU2—Metabolism of proteins—TUBA4A—amyotrophic lateral sclerosis	0.00579	0.0178	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00568	0.0175	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00568	0.0175	CbGpPWpGaD
Zanamivir—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.0056	0.00829	CcSEcCtD
Zanamivir—Rash—Riluzole—amyotrophic lateral sclerosis	0.00555	0.00822	CcSEcCtD
Zanamivir—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00554	0.00822	CcSEcCtD
Zanamivir—Headache—Riluzole—amyotrophic lateral sclerosis	0.00551	0.00817	CcSEcCtD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.00529	0.0163	CbGpPWpGaD
Zanamivir—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00523	0.00775	CcSEcCtD
Zanamivir—NEU2—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00519	0.016	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—DCTN1—amyotrophic lateral sclerosis	0.00492	0.0151	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.00483	0.0148	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—FIG4—amyotrophic lateral sclerosis	0.00454	0.014	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—DAO—amyotrophic lateral sclerosis	0.00411	0.0126	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—IGFBP3—amyotrophic lateral sclerosis	0.00363	0.0112	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—PLB1—amyotrophic lateral sclerosis	0.00311	0.00956	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—GSR—amyotrophic lateral sclerosis	0.00287	0.00882	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.00261	0.00804	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—CHAT—amyotrophic lateral sclerosis	0.00236	0.00725	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.00215	0.00661	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—IGF1—amyotrophic lateral sclerosis	0.00154	0.00472	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	0.00147	0.00453	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.00127	0.00389	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.00116	0.00358	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—APOE—amyotrophic lateral sclerosis	0.000958	0.00294	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000656	0.00202	CbGpPWpGaD
